Ratiometric Raman imaging reveals the new anti-cancer potential of lipid targeting drugs

Research output: Contribution to journalArticle

Abstract

De novo lipid synthesis is upregulated in cancer cells and inhibiting these pathways has displayed anti-tumour activity. Here we use Raman spectroscopy, focusing solely on high wavenumber spectra, to detect changes in lipid composition in single cells in response to drugs targeting de novo lipid synthesis. Unexpectedly, the beta - blocker propranolol showed selectively towards cancerous PC3 compared to non-cancerous PNT2 prostate cells, demonstrating the potential of this approach to identify new anti-cancer drug leads. A unique and simple ratiometric approach for intracellular lipid investigation is reported using statistical analysis to create phenotypic ‘barcodes’, a globally applicable strategy for Raman drug-cell studies. High wavenumber spectral analysis is compatible with low cost glass substrates, easily translatable into the cytological work stream. The analytical strength of this technique could have a significant impact on cancer treatment through vastly improved understanding of cancer cell metabolism, and thus guide drug design and enhance personalised medicine strategies.
LanguageEnglish
Pages6935-6943
Number of pages9
JournalChemical Science
Volume9
Issue number34
Early online date31 Jul 2018
DOIs
Publication statusPublished - 14 Sep 2018

Fingerprint

Lipids
Imaging techniques
Cells
Pharmaceutical Preparations
Oncology
Metabolism
Propranolol
Spectrum analysis
Medicine
Raman spectroscopy
Tumors
Statistical methods
Glass
Drug Delivery Systems
Substrates
Chemical analysis
Costs

Keywords

  • Raman spectroscopy
  • cancer
  • lipid metabolism
  • ratiometric analysis

Cite this

@article{d80676a2fbd94381920f5c7beb18db4b,
title = "Ratiometric Raman imaging reveals the new anti-cancer potential of lipid targeting drugs",
abstract = "De novo lipid synthesis is upregulated in cancer cells and inhibiting these pathways has displayed anti-tumour activity. Here we use Raman spectroscopy, focusing solely on high wavenumber spectra, to detect changes in lipid composition in single cells in response to drugs targeting de novo lipid synthesis. Unexpectedly, the beta - blocker propranolol showed selectively towards cancerous PC3 compared to non-cancerous PNT2 prostate cells, demonstrating the potential of this approach to identify new anti-cancer drug leads. A unique and simple ratiometric approach for intracellular lipid investigation is reported using statistical analysis to create phenotypic ‘barcodes’, a globally applicable strategy for Raman drug-cell studies. High wavenumber spectral analysis is compatible with low cost glass substrates, easily translatable into the cytological work stream. The analytical strength of this technique could have a significant impact on cancer treatment through vastly improved understanding of cancer cell metabolism, and thus guide drug design and enhance personalised medicine strategies.",
keywords = "Raman spectroscopy, cancer, lipid metabolism, ratiometric analysis",
author = "Jamieson, {Lauren E.} and Corinna Wetherill and Karen Faulds and Duncan Graham",
year = "2018",
month = "9",
day = "14",
doi = "10.1039/c8sc02312c",
language = "English",
volume = "9",
pages = "6935--6943",
journal = "Chemical Science",
issn = "2041-6520",
number = "34",

}

Ratiometric Raman imaging reveals the new anti-cancer potential of lipid targeting drugs. / Jamieson, Lauren E.; Wetherill, Corinna; Faulds, Karen; Graham, Duncan.

In: Chemical Science, Vol. 9, No. 34, 14.09.2018, p. 6935-6943.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Ratiometric Raman imaging reveals the new anti-cancer potential of lipid targeting drugs

AU - Jamieson, Lauren E.

AU - Wetherill, Corinna

AU - Faulds, Karen

AU - Graham, Duncan

PY - 2018/9/14

Y1 - 2018/9/14

N2 - De novo lipid synthesis is upregulated in cancer cells and inhibiting these pathways has displayed anti-tumour activity. Here we use Raman spectroscopy, focusing solely on high wavenumber spectra, to detect changes in lipid composition in single cells in response to drugs targeting de novo lipid synthesis. Unexpectedly, the beta - blocker propranolol showed selectively towards cancerous PC3 compared to non-cancerous PNT2 prostate cells, demonstrating the potential of this approach to identify new anti-cancer drug leads. A unique and simple ratiometric approach for intracellular lipid investigation is reported using statistical analysis to create phenotypic ‘barcodes’, a globally applicable strategy for Raman drug-cell studies. High wavenumber spectral analysis is compatible with low cost glass substrates, easily translatable into the cytological work stream. The analytical strength of this technique could have a significant impact on cancer treatment through vastly improved understanding of cancer cell metabolism, and thus guide drug design and enhance personalised medicine strategies.

AB - De novo lipid synthesis is upregulated in cancer cells and inhibiting these pathways has displayed anti-tumour activity. Here we use Raman spectroscopy, focusing solely on high wavenumber spectra, to detect changes in lipid composition in single cells in response to drugs targeting de novo lipid synthesis. Unexpectedly, the beta - blocker propranolol showed selectively towards cancerous PC3 compared to non-cancerous PNT2 prostate cells, demonstrating the potential of this approach to identify new anti-cancer drug leads. A unique and simple ratiometric approach for intracellular lipid investigation is reported using statistical analysis to create phenotypic ‘barcodes’, a globally applicable strategy for Raman drug-cell studies. High wavenumber spectral analysis is compatible with low cost glass substrates, easily translatable into the cytological work stream. The analytical strength of this technique could have a significant impact on cancer treatment through vastly improved understanding of cancer cell metabolism, and thus guide drug design and enhance personalised medicine strategies.

KW - Raman spectroscopy

KW - cancer

KW - lipid metabolism

KW - ratiometric analysis

UR - http://www.scopus.com/inward/record.url?scp=85052726954&partnerID=8YFLogxK

U2 - 10.1039/c8sc02312c

DO - 10.1039/c8sc02312c

M3 - Article

VL - 9

SP - 6935

EP - 6943

JO - Chemical Science

T2 - Chemical Science

JF - Chemical Science

SN - 2041-6520

IS - 34

ER -